12 Headache Medicine, v.2, n.1, p. 10-12, jan./feb./mar. 2011
Correspondence
DrDr
DrDr
Dr
. Ricardo A. Ricardo A
. Ricardo A. Ricardo A
. Ricardo A
. T. T
. T. T
. T
eixeiraeixeira
eixeiraeixeira
eixeira
Instituto do Cérebro de Brasília
SHLS 716 - Conjunto L - Centro Clínico Sul - Torre II
2
o
andar - Sala 211
70390-700 – Brasília, DF, Brazil
Tel. (61) 3346-5383 - Fax. (61) 3346-9102
ricardoateixeira@yahoo.com
Studies that used different stimuli (e.g.; CO2
inhalation, hyperventilation) reported normal
(5,6)
or
reduced
(7,8)
CR in the interictal period. Other studies using
methods such as Xenon blood flow studies, SPECT, PET,
and functional magnetic resonance also reported
discordant results. The different methods of CR
measurement is a major factor that limits comparison
between studies.
Migraineurs might have an increased CR during the
headache-free period due to alterations in their autonomic
tonus. These patients might have a state of vagal
hyperactivity during headache free periods leading to an
enhanced vasodilatatory response. Furthermore, it has been
reported that migraineurs present an enhanced secretion
and response to nitric oxid.
(15)
A previous comparison between tension-type
headache (TTH) and migraine using the transcranial
Doppler was performed by Rosengarten et al., measuring
the evoked flow velocity in the posterior cerebral artery
utilizing a visual stimulation paradigm.
(16)
This study
showed that TTH patients had similar flow velocity
response during the ictal and interictal periods, which
was also comparable to controls. The same evaluation
in migraineurs demonstrated that CR was reduced during
the ictal phase when compared to the interictal phase,
suggesting an impaired vasodilatation reserve during the
ictal phase.
Our study has several limitations. Individuals evaluated
in the ictal phase were not the same ones tested in the
interictal phase. We did not control for the presence of
carotid stenosis, which can influence the breath holding
index. However, the mean age of the migraineurs and
the control group was relatively low to be influenced by
this variable.
In addition, due to the wide BHI variability found
among migraineurs, it does not seem possible to set a
BHI cutoff value to define migraine using the transcranial-
Doppler. However, it is tempting to consider that a
significant CR variation between ictal and interictal phase
in a single patient could be an additional information to
the diagnosis of migraine. Further research evaluating CR
of the same patient during ictal and interictal phases of
migraine would be of great value.
REFERENCES
1. Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2010;
30(2):120-30.
2. Sanchez-Del-Rio M, Reuter U, Moskowitz MA. New insights into
migraine pathophysiology. Curr Opin Neurol. 2006;19(3):294-8.
3. Fiermonte G, Pierelli F, Pauri F, Cosentino FII, Soccorsi R,
Giacomini P. Cerebrovascular CO2 reactivity in migraine with
aura and without aura. A transcranial Doppler study. Acta Neurol
Scand. 1995;92(2):166-9.
4. Dora B, Balkan S. Exaggerated interictal cerebrovascular reactivity
but normal blood flow velocities in migraine without aura.
Cephalalgia. 2002;22(4):288-90.
5. Silvestrini M, Cupini LM, Troisi E, Matteis M, Bernardi G.
Estimation of cerebrovascular reactivity in migraine without aura.
Stroke. 1995;26(1):81-3.
6. Thomsen LL, Iversen HK, Olesen J. Increased cerebrovascular
pCO2 reactivity in migraine with aura - a transcranial Doppler
study during hyperventilation. Cephalalgia. 1995;15(3):211-5.
7. Anzola GP, Magoni M, Volta GD. Abnormal cerebrovascular
reactivity in headache free migraineurs - a transcranial Doppler
study. Cerebrovasc Dis. 1993;3:105-10.
8. Totaro R, Marini C, De Matteis G, Di Napoli M, Carolei A.
Cerebrovascular reactivity in migraine during headache-free
intervals. Cephalalgia. 1997;17(3):191-4.
9. Headache Classification Committee of the International
Headache Society. Classification and diagnostic criteria for
headache disorders, cranial neuralgias, and facial pain.
Cephalalgia. 1988;8(suppl 7):1-96.
10. The International Classification of Headache Disorders: 2nd
edition. Cephalalgia. 2004;24:9-160.
11. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart
WF; AMPP Advisory Group. Migraine prevalence, disease
burden, and the need for preventive therapy. Neurology.
2007;68(5):343-9.
12. Queiroz LP, Peres MF, Piovesan EJ, Kowacs F, Ciciarelli MC,
Souza JA, Zukermann E. A nationwide population-based study
of migraine in Brazil. Cephalalgia. 2009;29(6):642-9.
13. Schürks M, Buring JE, Kurth T. Agreement of self-reported migraine
with the ICHD-II criteria in the Women´s health study.
Cephalalgia. 2009;29(10):1086-1090.
14. Silvestrini M, Matteis M, Troisi E, Cupini LM, Bernardi G.
Cerebrovascular reactivity in migraine with and without aura .
Headache. 1996;36(1):37-40.
15. Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial
supersensitivity to nitric oxide (nitroglycerin) in migraine
sufferers. Cephalalgia. 1993;13(6):395-9.
16. Rosengarten B, Sperner J, Görgen-Pauly U, Kaps M.
Cerebrovascular reactivity in adolescents with migraine and
tension-type headache during headache-free interval and attack.
Headache. 2003;43(5):458-63.
SOUSA AC, GOMES CM, COELHO RS, TEIXEIRA RA